Mechanisms of FeNO Non-Suppression in Severe Asthma: Analysis of Sputum Type 2 Cytokines and Chemokines
S. Couillard (Oxford, United Kingdom), R. Shrimanker (Oxford, United Kingdom), G. Hynes (Oxford, United Kingdom), C. Borg (Oxford, United Kingdom), C. Connolly (Oxford, United Kingdom), A. Hayman (Oxford, United Kingdom), S. Poole (Oxford, United Kingdom), A. Moran (Oxford, United Kingdom), T. Powell (Oxford, United Kingdom), I. Pavord (Oxford, United Kingdom), T. Hinks (Oxford, United Kingdom)
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Session: Phenotypes of asthma and COPD
Session type: E-poster session
Number: 1111
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Couillard (Oxford, United Kingdom), R. Shrimanker (Oxford, United Kingdom), G. Hynes (Oxford, United Kingdom), C. Borg (Oxford, United Kingdom), C. Connolly (Oxford, United Kingdom), A. Hayman (Oxford, United Kingdom), S. Poole (Oxford, United Kingdom), A. Moran (Oxford, United Kingdom), T. Powell (Oxford, United Kingdom), I. Pavord (Oxford, United Kingdom), T. Hinks (Oxford, United Kingdom). Mechanisms of FeNO Non-Suppression in Severe Asthma: Analysis of Sputum Type 2 Cytokines and Chemokines. 1111
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: